Analyst Ratings for Immix Biopharma, Inc. (IMMX)
IMMX Rating Summary
IMMX Price Target Summary
- Highest: $23.00 (Citizens)
- Lowest: $15.00 (Mizuho)
- Average: $19.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.50 (+130.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$19.50 (+130.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2026 | Morgan Stanley | Judah Frommer | New Coverage | Overweight (N/A) |
20.00 (N/A) |
8.81 (8.45) |
-4.09% | Details |
| 3/9/2026 | Citizens » Updated 5/11/2026 |
Reni Benjamin | New Coverage | Market Outperform (N/A) |
23.00 (N/A) |
8.54 (8.45) |
-1.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
